DEL FABRO, vittorio
 Distribuzione geografica
Continente #
EU - Europa 104
NA - Nord America 87
AS - Asia 25
AF - Africa 1
Totale 217
Nazione #
US - Stati Uniti d'America 87
IE - Irlanda 40
SE - Svezia 28
PL - Polonia 20
IT - Italia 13
SG - Singapore 10
CN - Cina 7
IN - India 3
DE - Germania 2
JP - Giappone 2
VN - Vietnam 2
FI - Finlandia 1
ID - Indonesia 1
TN - Tunisia 1
Totale 217
Città #
Dublin 40
Chandler 20
Warsaw 20
Nyköping 19
Ashburn 8
Messina 8
Singapore 8
Dearborn 7
Princeton 6
Des Moines 4
Medford 4
Jinan 3
Ann Arbor 2
Bengaluru 2
Boardman 2
Dong Ket 2
Hiroshima 2
Jacksonville 2
New York 2
Cambridge 1
Hangzhou 1
Hyderabad 1
Jakarta 1
Jiaxing 1
Los Angeles 1
Munich 1
Nanjing 1
Redwood City 1
Rome 1
San Mateo 1
Sciacca 1
Tianjin 1
Villamagna 1
Wilmington 1
Totale 176
Nome #
Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network 68
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 52
Feasibility, Tolerability and Efficacy of Carfilzomib, Lenalidomide and Desamethasone (KRD) in Relapsed Refractory Myeloma Patients: A Real-Life Survey of the Sicilian Myeloma Network 46
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 45
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 19
Totale 230
Categoria #
all - tutte 1.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 8 1 0 1 0 0 0
2020/202140 5 6 6 2 6 2 5 2 2 2 0 2
2021/202229 0 2 2 1 2 0 0 0 1 7 1 13
2022/2023103 6 9 6 5 6 7 0 12 48 0 4 0
2023/202425 1 3 4 5 1 3 0 4 0 2 0 2
2024/202513 0 2 0 9 2 0 0 0 0 0 0 0
Totale 230